By Ana Espino | Published on January 12, 2026 | 3 min readAlzheimer’s disease (AD) is a
progressive neurodegenerative disorder and the leading cause of dementia
worldwide. Among modifiable risk factors,
excessive alcohol consumption has
drawn increasing attention. High-dose alcohol exposure is well known for its
neurotoxic effects; however,
its precise role in the development or worsening
of AD remains poorly defined.
Current limitations include a lack
of precise mechanistic data, the complexity of interactions between alcohol
exposure and brain aging, and the heterogeneity of clinical profiles. The main
challenge is to understand how chronic alcohol use disorder promotes
Alzheimer’s disease. Several mechanisms have been proposed, including
inflammation, oxidative stress, disruption of the blood–brain barrier, and
dysregulation of amyloid-β and tau proteins.
In this context, the present study
was initiated to synthesize current knowledge on the biological and clinical
links between
alcohol addiction and the risk or progression of Alzheimer’s
disease, by examining the underlying mechanisms and potential therapeutic
avenues.
Does alcohol accelerate
neurodegeneration?
This review is based on a narrative
analysis of the scientific literature, integrating
preclinical data (animal
models, cell cultures) and
clinical evidence (brain imaging, epidemiological
studies). The authors examine neurobiological mechanisms shared by both
conditions.
The findings indicate that chronic
alcohol exposure acts at multiple levels. It
accelerates brain atrophy,
increases blood–brain barrier permeability, and
promotes neuroinflammation. It
also enhances amyloid protein production and aggregation, as well as abnormal
tau phosphorylation—two hallmark features of Alzheimer’s disease.
Alcohol-related epigenetic modifications may further disrupt the expression of
genes involved in neuronal plasticity and cell survival.
Clinically, several epidemiological
studies report an
increased risk of dementia in individuals with
alcohol use
disorder, particularly when consumption begins early in life or persists over
several decades. Brain MRI studies confirm
structural and functional
alterations common to both conditions, notably in the hippocampus and
prefrontal cortex.
A silent threat that requires better
anticipation
Alzheimer’s disease is a
progressive
neurodegenerative disorder with a multifactorial origin that potentially
includes
chronic alcohol consumption. Understanding the
mechanisms linking
these two conditions is a major challenge for both prevention and the
adaptation of therapeutic strategies.
The aim of this review was to
explore the biological and clinical connections between chronic alcoholism and
the development or worsening of Alzheimer’s disease. It highlights several
shared mechanisms, suggesting an
aggravating role of alcohol in neurodegeneration.
However, limitations remain and
justify further research. Future work should include longitudinal clinical
studies, improved stratification of drinking patterns, dose–response analyses,
and the evaluation of preventive approaches combining alcohol reduction with
neuroprotective strategies.
Read next: Cross-addictions: when drugs and alcohol reinforce each other
About the author – Ana EspinoPhD in Immunology, specialized in Virology
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions through impactful communication.